Search For "dcgi"
Johnson & Johnson won't be conducting COVID-19 vaccine trials in India
Updated : 4 years, 8 months ago IST
New Delhi [India], June 29 (ANI): Johnson & Johnson will not be conducting local trials in India for its single-dose COVID-19 vaccine, a spokesperson of the US-based pharma company said on Tuesday.
Read More
Cipla seeks DCGI nod for import of Moderna's COVID-19 vaccine: Sources
Updated : 4 years, 8 months ago IST
New Delhi [India], June 29 (ANI): The Mumbai-based pharmaceutical multinational Cipla, on behalf of the US pharma major Moderna, has requested for import and marketing authorisation of its COVID-19 vaccines.
Read More
DCGI likely to approve phase 3 trial data of Covaxin on Tuesday
Updated : 4 years, 8 months ago IST
New Delhi [India], June 22 (ANI): The Drugs Controller General of India (DCGI) is likely to approve Phase III trial data of Covaxin on Tuesday, sources said.
Read More
DCGI's expert panel to review Phase III data of Covaxin today
Updated : 4 years, 8 months ago IST
New Delhi [India], June 22 (ANI): The Subject Expert Committee (SEC) under the drug regulator will discuss reviewing the Phase III data of Bharat Biotech's Covaxin on Tuesday.
Read More
Bharat Biotech has submitted Covaxin's Phase III trial data to DCGI: Govt
Updated : 4 years, 8 months ago IST
New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India (DCGI) over the weekend, according to government sources.
Read More
DCGI grants SII permission to manufacture Sputnik V for specific regulator
Updated : 4 years, 9 months ago IST
New Delhi [India], June 4 (ANI): The Drug Controller General of India (DCGI) on Friday granted the approval to the Serum Institute of India (SII) for the initial manufacture of the Russian COVID-19 vaccine Sputnik V for testing, examination, and analysis purposes with certain conditions at i
Read More
Children can't be vaccinated currently, trials on below 18 underway: Centr
Updated : 4 years, 9 months ago IST
New Delhi [India], June 4 (ANI): Centre through an affidavit on Friday informed the Delhi High Court that on May 12, 2021, the Drug Controller General of India (DCGI) has permitted Bharat Biotech to conduct clinical trials on healthy volunteers between 2 years to 18 years of age for its vacc
Read More
Visakhapatnam: Drug control officer says DCGI gave permission to extend Re
Updated : 4 years, 9 months ago IST
Visakhapatnam (Andhra Pradesh) [India], June 3 (ANI): Refuting allegations that Remdesivir injections, which were expired in March 2021, were administered to patients in Area Hospital, Narsipatnam, the District Drug Control has informed that Drugs Control General of India (DCGI) had given pe
Read More
Plea in Delhi HC seeking stay on Phase II/III clinical trial of Covaxin in
Updated : 4 years, 9 months ago IST
New Delhi [India], June 3 (ANI): A Fresh application was moved in Delhi High Court on Thursday seeking to stay the operation of the order of Drugs Controller General of India (DCGI) for conducting phase II/III clinical trials of Whole Virion Inactivated Coronavirus Vaccine in the 2 to 18 yea
Read More
SII seeks DCGI's permission for test license to manufacture Sputnik V COVI
Updated : 4 years, 9 months ago IST
New Delhi [India], June 3 (ANI): Indian vaccine manufacturing company Serum Institute of India (SII) has sought permission from the Drug Controller General of India (DCGI) for the production of the Russian vaccine Sputnik V in India.
Read More
DCGI waiver likely to bring foreign vaccines like Pfizer, Moderna a step c
Updated : 4 years, 9 months ago IST
New Delhi [India], June 2 (ANI): The Drugs Controller General of India (DCGI) has done away with specific trials of COVID-19 vaccines that have been approved by other international regulatory bodies - a big move likely to clear the way for foreign vaccines like Pfizer and Moderna for the
Read More
Eli Lilly's antibody cocktail drug gets emergency use nod in India
Updated : 4 years, 9 months ago IST
New Delhi [India], June 1 (ANI): Eli Lilly and Company India on Tuesday announced that it has received emergency use approval in the country for its monoclonal antibody drug combination used for treating Covid-19 patients with mild to moderate symptoms.
Read More